Expedition, a startup searching for drugs from China, cuts its first deal
The startup agreed to pay Fosun Pharma as much as $645 million for a drug in testing for multiple lung conditions, including bronchiectasis.
Previous Post
STAT+: Pfizer drug extends survival for some bladder cancer patients
Next Post
The Power of Podcasting for Healthcare
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago